Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Collaborating with Florida International University

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Collaboration to further advance the identification and characterization of designer drugs.

Agilent Technologies Inc. has announced that it is collaborating with Florida International University’s department of chemistry and biochemistry and its International Forensics Research Institute to further advance the identification and characterization of so-called designer drugs.

This work is currently focused on developing and validating new methods for rapid forensic screening and analysis based on advanced chromatography and mass-spectrometry systems such as LC-QQQ-MS/MS, LC-QTOF-MS, GC/MS and GC/MS/MS.

The new methods will expand the capabilities of traditional drug-screening procedures involving immunoassays.

“Since routine immunoassay drug-screening methods are unable to detect most of the hundreds of individual designer drugs that have been identified, we are working with Agilent to develop advanced analytical methods to screen and confirm the presence of such drugs in both ante- and post-mortem specimens,” said Dr. Anthony DeCaprio, associate professor and director of the Forensic & Analytical Toxicology facility at Florida International University’s International Forensic Research Institute.

Dr. DeCaprio continued, “Recently, we validated a method for the detection and quantification of 32 designer drugs in serum, including 24 phenethylamines, four piperazines, and four tryptamines. In collaboration with Agilent, we will continue to expand our tandem mass-spectral library to approximately 300 designer drugs.”

Dr. DeCaprio will present data of interest to forensic scientists and toxicologists in an e-seminar on Tuesday, Feb. 26, as part of a six-seminar series (live and on-demand) at ForensicEd.org.

To learn more about the Florida International University designer drug program, visit “Targeted LC-QQQ MS Screening of Cathinone Derivitaves and Other Designer Drugs in Serum.”

Designer drugs are novel analogs or derivatives of existing illicit drug compounds that are synthesized to circumvent existing laws and to produce similar effects as illegal recreational drugs.

Major classes of designer drugs include phenethylamines, cathinones, tryptamines, piperazines, and synthetic cannabinoids. For years, black-market laboratories could produce and distribute these drugs with little to no threat of prosecution, until last summer when U.S. President Obama signed a bill into law designating certain chemicals found in designer drugs as illegal substances.

Today, as with other illicit drugs already covered under federal law, selling and distributing many specific designer drugs is now prohibited in the United States.

“It is our goal to provide private, academic and government institutions with sophisticated technology and screening methods that will quickly and accurately identify these substances so that laws enacted to restrict their use can be readily enforced,” said Tom Gluodenis, Agilent’s global marketing manager of Forensics and Toxicology.

Gluodenis continued, “We look forward continuing our work with Dr. DeCaprio and his team at Florida International University, and commend them on their ambitious efforts in this important area of research.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Wins Award for Innovation in LC
Dual-needle technology enhances speed, flexibility.
Thursday, January 28, 2016
Agilent Completes Acquisition of Seahorse Bioscience
Agilent has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics.
Tuesday, November 03, 2015
Agilent to Acquire Seahorse Bioscience
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings.
Thursday, September 10, 2015
Agilent, Singapore Institute Collaborate
Agilent Technologies and Singapore's Bioprocessing Technology Institute today announced a collaboration to develop new analytical approaches to specific protein-linked sugar compounds.
Wednesday, July 15, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Agilent, Baylor Open Mass Spec Center of Excellence
The new facility aims to boost metabolomics research at Baylor College of Medicine.
Friday, December 05, 2014
Agilent, MRM Proteomics Extend Agreement
Agreement expands on an existing collaboration established in 2012, allowing both organizations to bolster their combined proteomics solutions, comprising reagent kits, hardware and software.
Friday, July 25, 2014
Agilent to Celebrate Customer Achievements at ASMS Conference
Company to introduce instruments, software and services enabling researchers to set new standards in mass spectrometry, lab productivity.
Thursday, June 12, 2014
Agilent, SISCAPA Sign Protein Quantitation Agreement
Companies sign a non-exclusive agreement to enable SISCAPA to provide an end-to-end solution using a highly automated workflow for LC-MS.
Tuesday, May 27, 2014
Agilent Thought Leader Award Supports Metabolic Research
Princeton team developing LC/MS methods, bioinformatics tools for discovery of metabolic regulatory mechanisms.
Tuesday, April 22, 2014
Agilent, University of Arizona to Host Environmental Analysis Techniques Workshop
Dr. Shane Snyder, EPA Scientists, Leading Environmental Labs to Present Data on Recycled Water, Hydraulic Fracturing, Trace Contaminants in Water.
Monday, March 10, 2014
Agilent's LC/MS Purification System a Winner in Analytical Scientist Innovation Awards
Magazine names 1260 Infinity series one of top 15 game-changing technologies of 2013.
Saturday, February 22, 2014
Agilent Announces Agreement with Picometrics Technologies
Agilent to provide Picometrics' biopharmaceutical customers with combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection and mass spectrometry.
Friday, January 17, 2014
Agilent Awards Grant for Translational Research in Cardiometabolic Disease
Dr. Christopher Newgard's team at Duke University use Agilent platforms to better understand disease mechanisms.
Thursday, January 16, 2014
Scientific News
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Determination of 13 Organic Toxicants in Human Blood
Researchers have utilised liquid-liquid extraction coupling HPLC-MS/MS to identify and quantify organic toxicants in human blood.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
Massive Helium Discovery a "Game Changer" for Medical Industry
A new development is gas exploration has yielded the discovery of a huge helium gas field, which could help relieve the dwindling supply.
Unidentified Spectra Detector
New algorithm clusters over 250 million spectra for analysis, such that millions of unidentified peptide sequences can be recognised.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!